Long-term safety and serologic response to measles, mumps, and rubella vaccination in HIV-1 infected adults.
about
Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand.Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II.Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization?Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in Germany.British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015.
P2860
Long-term safety and serologic response to measles, mumps, and rubella vaccination in HIV-1 infected adults.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Long-term safety and serologic ...... tion in HIV-1 infected adults.
@ast
Long-term safety and serologic ...... tion in HIV-1 infected adults.
@en
Long-term safety and serologic ...... tion in HIV-1 infected adults.
@nl
type
label
Long-term safety and serologic ...... tion in HIV-1 infected adults.
@ast
Long-term safety and serologic ...... tion in HIV-1 infected adults.
@en
Long-term safety and serologic ...... tion in HIV-1 infected adults.
@nl
prefLabel
Long-term safety and serologic ...... tion in HIV-1 infected adults.
@ast
Long-term safety and serologic ...... tion in HIV-1 infected adults.
@en
Long-term safety and serologic ...... tion in HIV-1 infected adults.
@nl
P2093
P2860
P1433
P1476
Long-term safety and serologic ...... tion in HIV-1 infected adults.
@en
P2093
Amy C Weintrob
Benjamin M Stermole
Brychan M Clark
Grace E Macalino
Greg A Grandits
Michael L Landrum
Mollie P Roediger
Nancy F Crum-Cianflone
Tomas M Ferguson
P2860
P304
P356
10.1016/J.VACCINE.2011.02.013
P407
P577
2011-02-23T00:00:00Z